# SCAI THERAPEUTICS

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/scai-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Daejeon, South Korea
- Website: www.scaitrx.com
- Total disclosed funding: $39M
- Latest round: Series C (Jul 10, 2026)
- Investors on record: 11

## About

Based in Seoul, South Korea and founded in 2019, SCAI THERAPEUTICS is a company that develops pharmaceutical technology to increase the bioavailability of drugs. Bioavailability refers to the effect that a certain amount of a drug exerts in the body. Drugs show different efficacy depending on various factors such as crystalline form, purity, and formulation form. In July 2026, SCAI THERAPEUTICS raised KRW 13 billion in series C funding from new investors BonAngels Venture Partners and Solid X. Other unspecified investors also participated in this round.


The company operates a drug delivery platform technology, MOASIS. Molecularly Associated Innovative Substance (MOASIS) enables the construction of novel molecular clusters from small molecules within critical length scales.

The company will use the July 2026 funding to accelerate phase two clinical trials for its wet macular degeneration treatment and establish a global mass production system for cosmetic raw materials and sunscreen boosters.

## Funding rounds

- Series C, Jul 10, 2026, $8.6M — BonAngels Venture Partners, Solid X
- Series B, Jul 14, 2021, $28M — HB Investment, IMM Investment, Timefolio Asset Management, Heungkuk Securities, EUM Private Equity, Stonebridge Ventures, Lifecore Partners, Forward Equity Partners, KIWOOM Capital
- Series A, Sep 1, 2019, $2.5M — Stonebridge Ventures

## Investors

- Stonebridge Ventures — Series A, Series B
- HB Investment (https://capitalatlas.ai/funds/hb-investment) — Series B
- IMM Investment (https://capitalatlas.ai/funds/imm-investment) — Series B
- Timefolio Asset Management — Series B
- Heungkuk Securities — Series B
- EUM Private Equity (https://capitalatlas.ai/funds/eum-private-equity) — Series B
- Lifecore Partners — Series B
- Forward Equity Partners (https://capitalatlas.ai/funds/forward-equity-partners) — Series B
- KIWOOM Capital (https://capitalatlas.ai/funds/kiwoom-capital) — Series B
- BonAngels Venture Partners (https://capitalatlas.ai/funds/bonangels-venture-partners) — Series C
- Solid X (https://capitalatlas.ai/funds/solid-x) — Series C